Chapter 221 Reactions from all parties
Cai Tao wandered back and forth at the door of the office, looking anxious and uneasy.
He also learned from the news that the company's drugs would not be launched in China for the time being.
As soon as he learned the news, Cai Tao hurried over to find Joey.
He didn't understand what Joey was thinking to make such a decision.
However, there are other people in Joey's office now, and Cai Tao can't go in, so he can only wait anxiously outside.
After a long time, Cai Tao finally heard the sound of chairs being moved in the office. Then the office door was opened, and a company employee left the office with documents.
After there was no one else in the office, Cai Tao walked into the office. At this moment, Joey was drinking coffee leisurely.
Cai Tao closed the door of the office, and Joey also noticed the movement. He looked up and found out that the person coming was Cai Tao. He raised his eyebrows, put down the coffee and said, I remember I told you But before you come in, you have to knock on the door.
Cai Tao did not answer Joey's words. He was no longer in the mood to discuss these things with Joey.
After Cai Tao sat down on the chair opposite Joey, he took a deep breath and said, I saw the company's decision in the newspaper.
Really, I originally planned to tell you later, but now that you already know, there's no need. Joey said with a smile.
Cai Tao frowned and said, But, I don't understand, why do you do this?
Joey shrugged and said lightly: It's very simple. Since Lu Liang is unwilling to cooperate with us, then we can only think of other ways, right?
Cai Tao frowned and said, But the question is, if you do this, do you think he will give in? Do you think things are too simple?
Joey tapped his fingers on the table and said calmly: How will you know if you don't try?
Cai Tao sneered: It's not like you haven't tried it before. For the previous liver cancer treatment drugs, we combined Bayer and other companies, but the final result was?
They developed new anti-liver cancer drugs and made technological breakthroughs, but it was us who suffered heavy losses.
Joey still replied calmly: Cai Tao, you have enough professionalism. You should know that one failure does not mean that the method is not good. Maybe you will succeed after trying a few more times.
Cai Tao twitched the corner of his mouth: Then don't be afraid. Just like before, he broke through your technological blockade and developed a new targeted drug for pancreatic cancer.
However, Cai Tao's words did not change Joey's expression too much: I have already considered this, but even so, this method is still worth trying.
After all, even if we fail, the final result will be that the new pancreatic cancer targeted drug loses the Chinese market, but don't forget, we still have a global market, and these losses are still within the range we can bear.
Cai Tao opened his mouth, not knowing how to refute for a moment.
When Joey saw that Cai Tao was no longer talking, he said, If there are no other questions, I think you should do your job now.
Cai Tao was silent for a while, then stood up and prepared to leave Joey's office.
When Cai Tao walked to the door of the office, Joey's voice once again caught up with him from behind: By the way, next time you come in, remember to knock on the door first.
In the conference room.
It's too much. This is getting more and more excessive. It doesn't take us seriously at all!
Someone slapped the table and said angrily.
This meeting was an impromptu meeting. The content of the meeting was mainly to discuss the issue of Pfizer's pancreatic cancer drug not being launched in China.
I pretended to do it before, but now I don't even pretend it, I just point it out! Someone spat and accused Pfizer of this behavior.
Okay, Director Qi, no matter how much you scold me, others won't lose a piece of flesh. If you have this skill, let's discuss some solutions. In the conference room, the leader said.
As soon as these words were spoken, the conference room suddenly became quiet.
At this time, the man said again: This time, I specially invited several representatives from the pharmaceutical company. I wonder if these representatives have any opinions on this matter?
Silence fell in the conference room. The silence lasted for a while and then was broken.
The first person to express his position was the representative of Hengrui Company: To be honest, our company is actually very indignant about this matter, and we also want to contribute our own strength to this matter.
But unfortunately, our company now has an important pharmaceutical project under development, and the company has invested a lot of money and manpower in this project.
At present, our company may not be able to spare funds and manpower for the development of pancreatic cancer drugs, and we are helpless in this matter.
These words are so flawless that no one can find any faults.
Just as the representative of Hengrui Company finished speaking, another representative of a pharmaceutical company also quickly said: Our company's main business is mainly focused on generic drugs.
Our company is still in the exploratory stage in the development of original drugs, and its business capabilities are not very proficient. It is not an area that our company is good at.
Moreover, if it turns out to be pancreatic cancer, our company may not have the capability.
Immediately afterwards, one or two representatives from pharmaceutical companies spoke one after another, and the contents of their speeches were mostly the same. Basically, they all found various excuses to decline.
For a moment, the atmosphere in the conference room was a little solemn.
After all, no one is a fool, and everyone can see that this matter was purely directed at a certain person from the beginning.
To put it bluntly, this matter has nothing to do with any of these pharmaceutical companies.
Anyway, it doesn't affect their company. There is no need for them to wade into this muddy water and bother to develop some original research drugs.
And it is pancreatic cancer, which is known as the king of cancers.
Listening to the speeches of several pharmaceutical company representatives, the leader in the conference room also sighed helplessly.
Although he did not expect that a solution to the problem could be discussed through this meeting, he also did not expect such a result.
Although in the end, representatives of various pharmaceutical companies promised that the company would start developing pancreatic cancer treatment drugs as soon as possible.
But everyone knows in their hearts that most of these words are just words, and no one will actually take action.
In the end, the whole meeting could only end in a hurry.